Vanda Pharmaceuticals Inc.
USE OF TRADIPITANT IN MOTION SICKNESS

Last updated:

Abstract:

Disclosed herein is a method of treating or preventing motion sickness or at least one symptom thereof, comprising treatment with the NK-1 receptor antagonist, tradipitant.

Status:
Application
Type:

Utility

Filling date:

28 Apr 2022

Issue date:

11 Aug 2022